NCT04027361: Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD) |
|
|
| Completed | 2 | 41 | US | Amphetamine Extended Release (ER) Tablet 20 mg, Amphetamine extended-release oral tablet 20 mg | Tris Pharma, Inc., Massachusetts General Hospital, Massachusetts Institute of Technology | ADHD | 10/21 | 10/21 | | |